Project Grant 2346917

Award Date 5/1/24
Completion Date 4/30/26
Dollars Obligated $199K
Federal Grant Program
47.041
Assistance Type
Project Grant
Place of Performance
Lakeland, FL 33805, USA
Similar Awards
This $463,693 federal Project Grant award from the National Science Foundation's (NSF) Engineering program (CFDA 47.041) will fund the development of an "Integrated Framework for Recording and Decoding Multimodal Neural Associations of Visual Hallucinations and Motor Functions in Parkinson's Disease." The primary research institution is the University of Rhode Island, which will collaborate with Butler Hospital to execute this 3-year project starting September 2024. The project aims to...
This National Science Foundation project grant of $156,238 awarded on January 1, 2023 will fund research at Colorado State University to develop analytical tools combining heterogeneous genetic and molecular data sources to identify genetic modifiers of Parkinson's disease. Under the Mathematical and Physical Sciences program (CFDA 47.049), the researchers will use a hierarchical three-group mixture model to probabilistically model genes as null, deleterious, or beneficial based on genome-wide...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award of $275,000 to Brainstorm Therapeutics, Inc. aims to develop and validate a novel Parkinson's disease drug discovery platform using patient-derived midbrain organoids. The platform will guide therapeutic candidate identification, patient selection, and trial endpoint refinement to accelerate the development of effective disease-modifying Parkinson's treatments. Key innovations...
This National Science Foundation (NSF) Division of Chemical, Bioengineering, Environmental, and Transport Systems grant awarded to Purdue University, under CFDA 47.041 Engineering, provides $248,827 to develop a fluorescent imaging method to study protein-membrane interactions in brain cells. This research aims to further the understanding of Parkinson's disease, which may be caused by the clumping and spread of the alpha-synuclein protein in the brain. The project involves two graduate students...
The federal Project Grant award of $173,140 from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, will support research to elucidate the role of neural activity in the degeneration of midbrain dopamine neurons in Parkinson's disease. The project aims to utilize novel mouse models to chronically manipulate the activity and dopamine metabolism within dopamine neurons,...
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $466,125.00 to New York University School of Medicine to conduct research on the neural substrates underlying the long-duration response in Parkinson's disease. The project aims to uncover the mechanisms by which repeated stimulation of certain neurons in the globus...
The National Science Foundation awarded Quadralynx Inc. a $255,750 Project Grant under the NSF Technology, Innovation, and Partnerships program (CFDA 47.084) to develop a biofeedback system for adults with Parkinson's disease. The grant period runs from December 15, 2021 through July 31, 2022 in Spokane, Washington. Under this award, Quadralynx will deliver a biofeedback system utilizing sensors and software to help adults with Parkinson's disease improve motor function through interactive...
This $800,000 National Science Foundation project grant will fund research at Florida Atlantic University to develop technology enabling disabled individuals to control advanced prosthetic devices. Specifically, the grant will support exploration of novel bimodal skin sensors, investigation of machine learning algorithms to classify user intent, and creation of a reinforcement learning paradigm for customized muscle training exercises. The goal is to empower those with upper limb deficiencies to...
This $684,451 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program supports comprehensive research to advance understanding and treatment of Parkinson's disease (PD). The project aims to: Identify PD progression subtypes through integrative modeling of longitudinal clinical, transcriptomic, and neuroimaging data from the Parkinson's Progression...
This National Science Foundation (NSF) Project Grant under CFDA 47.075 - Social, Behavioral, and Economic Sciences aims to investigate how the human brain coordinates sensory inputs to enable complex movement and balance. The $489,062 award to The Pennsylvania State University supports research using virtual reality and robotic technology to study how visual, proprioceptive, and vestibular systems work together during interactions with moving objects. The project will develop computational...

This federal Project Grant award, funded by the National Science Foundation (NSF) Engineering program (CFDA 47.041), will support research to investigate how changes in brain function due to Parkinson's disease (PD) impact movement dysfunction. The $199,401 award to Florida Polytechnic University, a state-controlled institution of higher learning, will employ modeling, simulation, and robotic-based movement studies to gain insights into the neural mechanisms underlying both inhibitory and excitatory motor symptoms in PD. The research aims to bridge the gap between pathophysiological studies and motor control theories, with the goal of informing improved treatments, rehabilitation, and diagnostic strategies for PD. In addition, the project will include outreach events using robotic devices to promote STEM interest and training among students, particularly those from low-income backgrounds, at the university. No sub-awards are planned under this grant, which has a period of performance from May 1, 2024 to April 30, 2026.

Generated 1/28/25, 8:07 AM